Neomera BioLab, Inc.
Neomera BioLab is a peptide therapeutics company building a differentiated drug discovery platform to redefine chronic pain treatment and unlock next-generation therapeutics for complex disorders. The company addresses a major challenge in drug discovery, achieving precise control and selectivity across difficult targe
Based, Neomera BioLab, Inc. works in advanced therapies.
Profile
Neomera BioLab is a peptide therapeutics company building a differentiated drug discovery platform to redefine chronic pain treatment and unlock next-generation therapeutics for complex disorders. The company addresses a major challenge in drug discovery, achieving precise control and selectivity across difficult target classes, especially membrane proteins. By unifying AI and experimental biology into a single […]
The company sits in the advanced therapies segment, where it competes on its core product or service.
The company is listed at the Creative Destruction Lab alumni company stage of development.
| Sector | Advanced Therapies |
|---|---|
| Stage | Creative Destruction Lab alumni company |
Website: www.neomerabiolab.com
Browse related
Create a free account